[The efficacy of immunomodulating therapy in patients with chronic cholestatic liver diseases].
The use is studied of the immunomodulating agents splenin and vilosen in a combined therapy of 93 patients with chronic cholestatic disorders of the liver. The above drug combination was found to have a positive effect on both the immune status and condition of microhemodynamics, with the clinical parameters getting improved, duration of remission lengthened.